# UCB Pharma SA clinical trials: 28 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 28 trials with UCB Pharma SA as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by UCB Pharma SA: 28 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/ucb-pharma-sa

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 28
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 28, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| February 19, 2015 | NCT02365948 | A Study of Certolizumab Pegol to Evaluate Pharmacokinetics and Safety in Adult Healthy Chinese Subjects | UCB Pharma SA | Phase 1 | Completed | Healthy Subjects | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02365948) |
| December 18, 2014 | NCT02319642 | An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044 | UCB Pharma SA | Phase 3 | Completed | Rheumatoid Arthritis | 347 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02319642) |
| February 25, 2014 | NCT02070796 | Single-site, Open-label, Randomized, Cross-over Study in Healthy Chinese Subjects to Evaluate the Bioequivalence of Single-dose Rotigotine... | UCB Pharma SA | Phase 1 | Completed | Healthy | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02070796) |
| November 18, 2013 | NCT01986608 | Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese Subjects | UCB Pharma SA | Phase 1 | Completed | Healthy Volunteers | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01986608) |
| October 1, 2013 | NCT01954121 | Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures | UCB Pharma SA | Phase 3 | Completed | Epilepsy, Partial Seizures | 436 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01954121) |
| April 15, 2013 | NCT01832038 | Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset... | UCB Pharma SA | Phase 3 | Completed | Epilepsy, Partial-onset Seizures | 473 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01832038) |
| February 22, 2013 | NCT01796899 | Comparison of Brivaracetam Oral Tablet (10 mg, 50 mg, 75 mg and 100 mg) and Brivaracetam Injection (100 mg) in Healthy Volunteers | UCB Pharma SA | Phase 1 | Completed | Healthy Volunteers | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01796899) |
| January 9, 2013 | NCT01764321 | Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) Inhibitors | UCB Pharma SA | Observational | Completed | Rheumatoid Arthritis | 1,723 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01764321) |
| November 16, 2012 | NCT01728077 | Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy | UCB Pharma SA | Phase 3 | Completed | Epilepsy | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01728077) |
| October 19, 2012 | NCT01710670 | A Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male Subjects | UCB Pharma SA | Phase 1 | Completed | Healthy Volunteers | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01710670) |
| October 19, 2012 | NCT01710657 | A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures | UCB Pharma SA | Phase 3 | Completed | Epilepsy, Partial Onset Seizures | 548 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01710657) |
| July 30, 2012 | NCT01653262 | Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV) | UCB Pharma SA | Phase 3 | Completed | Epilepsy | 29 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01653262) |
| February 3, 2012 | NCT01526434 | Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol | UCB Pharma SA | Observational | Completed | Rheumatoid Arthritis | 81 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01526434) |
| January 27, 2012 | NCT01519882 | Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's Disease | UCB Pharma SA | Phase 4 | Terminated | Advanced Idiopathic Parkinson's Disease | 1 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01519882) |
| January 27, 2012 | NCT01519791 | A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination... | UCB Pharma SA | Phase 3 | Completed | Rheumatoid Arthritis | 880 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01519791) |
| December 28, 2011 | NCT01500278 | Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in... | UCB Pharma SA | Phase 4 | Completed | Rheumatoid Arthritis | 915 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01500278) |
| June 2, 2011 | NCT01364597 | Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy | UCB Pharma SA | Phase 3 | Completed | Epilepsy | 257 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01364597) |
| July 25, 2007 | NCT00505934 | Open-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy | UCB Pharma SA | Phase 2 | Completed | Epilepsy | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00505934) |
| July 20, 2007 | NCT00504881 | Brivaracetam as add-on Treatment in Adolescents and Adults Suffering From Epilepsy | UCB Pharma SA | Phase 3 | Completed | Epilepsy | 480 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00504881) |
| June 22, 2007 | NCT00490035 | Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures | UCB Pharma SA | Phase 3 | Completed | Epilepsy | 399 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00490035) |
| July 27, 2006 | NCT00357669 | Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults | UCB Pharma SA | Phase 3 | Completed | Unverricht-Lundborg Disease | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00357669) |
| June 29, 2006 | NCT00345800 | Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes | UCB Pharma SA | Phase 1 | Completed | Narcolepsy With Cataplexy | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00345800) |
| September 12, 2005 | NCT00160706 | A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031... | UCB Pharma SA | Phase 3 | Completed | Crohn's Disease | 310 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00160706) |
| September 12, 2005 | NCT00160524 | A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031... | UCB Pharma SA | Phase 3 | Completed | Crohn's Disease | 596 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00160524) |
| September 9, 2005 | NCT00152503 | Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam | UCB Pharma SA | Phase 2 | Completed | Epilepsy, Partial | 59 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00152503) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 6 |
| Phase 2 | 2 |
| Phase 3 | 16 |
| Phase 4 | 2 |
| Observational | 2 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 27 |
| Terminated | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Epilepsy | 11 |
| Arthritis, Rheumatoid | 5 |
| Crohn Disease | 2 |
| Epilepsy, Generalized | 1 |
| Epilepsies, Partial | 1 |
| Sleep Wake Disorders | 1 |
| Epilepsy, Tonic-Clonic | 1 |
| Narcolepsy | 1 |
| Seizures | 1 |
| Dermatitis, Atopic | 1 |
| Asthma | 1 |
| Unverricht-Lundborg Syndrome | 1 |
| Myoclonic Epilepsies, Progressive | 1 |
| Myoclonus | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Paving contractors in the United States](https://specstream.ai/data/businesses/paving-contractors/united-states)
- [Optometrists in the United States](https://specstream.ai/data/businesses/optometrists/united-states)
- [Moving companies in the United States](https://specstream.ai/data/businesses/moving-companies/united-states)
- [Medical supply stores in the United States](https://specstream.ai/data/businesses/medical-supply-stores/united-states)
- [Machine shops in the United States](https://specstream.ai/data/businesses/machine-shops/united-states)
- [Landscaping companies in the United States](https://specstream.ai/data/businesses/landscaping-companies/united-states)
